Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S James

Showing results (311-320 of 1,841) with videos related to

Pageof 185
Sort By:
AIDS Treatment News|May 22, 2001
Agouron and immune response to commercialize remune immune-based treatmentJ S James
AIDS Treatment News|May 22, 2001
Efavirenz (Sustiva) may equal or exceed protease inhibitor in initial antiretroviral combinationJ S James
AIDS Treatment News|May 22, 2001
Fusion inhibitors, T-20; chemokine variants; tat and interferon antibodies: Gallo describes three new treatment approachesJ S James
AIDS Treatment News|January 5, 2002
T-20 small program, CD4 < 50, will enroll November 27 at 3:00 P.MJ S James
AIDS Treatment News|January 5, 2002
Treatment news from recent conferences: finding Web reportsJ S James
AIDS Treatment News|January 5, 2002
Anthrax, bioterrorism fears stimulate immune, other researchJ S James
AIDS Treatment News|September 8, 2001
United Nations: civil society snubbed at final preparatory meetings on AIDSJ S James
AIDS Treatment News|September 8, 2001
European Parliament supports treatment access in developing countriesJ S James
AIDS Treatment News|September 11, 2001
United Nations: special AIDS session next weekJ S James
AIDS Treatment News|January 20, 1995
1995 outlook: research strategyJ S James
Pageof 185

Showing results (311-320 of 1,841) with videos related to

Sort By:
Pageof 185
AIDS Treatment News|May 22, 2001
Agouron and immune response to commercialize remune immune-based treatmentJ S James
AIDS Treatment News|May 22, 2001
Efavirenz (Sustiva) may equal or exceed protease inhibitor in initial antiretroviral combinationJ S James
AIDS Treatment News|May 22, 2001
Fusion inhibitors, T-20; chemokine variants; tat and interferon antibodies: Gallo describes three new treatment approachesJ S James
AIDS Treatment News|January 5, 2002
T-20 small program, CD4 < 50, will enroll November 27 at 3:00 P.MJ S James
AIDS Treatment News|January 5, 2002
Treatment news from recent conferences: finding Web reportsJ S James
AIDS Treatment News|January 5, 2002
Anthrax, bioterrorism fears stimulate immune, other researchJ S James
AIDS Treatment News|September 8, 2001
United Nations: civil society snubbed at final preparatory meetings on AIDSJ S James
AIDS Treatment News|September 8, 2001
European Parliament supports treatment access in developing countriesJ S James
AIDS Treatment News|September 11, 2001
United Nations: special AIDS session next weekJ S James
AIDS Treatment News|January 20, 1995
1995 outlook: research strategyJ S James
Pageof 185